Kalayani Drugs Private Limited - Company Profile

It is a manufacturing private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Kalayani Drugs Private Limited

Kalayani Drugs Private Limited, a struck off private limited company, was established on 11 August 2017 in Mumbai, Maharashtra, India. Engaging in other within the manufacturing sector, it holds CIN: U36990MH2017PTC298532. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Sangharsh Singh (Additional Director), Anuradha Krishna Hedge (Director), Udai Bhanu Singh (Director). It is based at 201, Wood Row, Plot -19, Shah Industrial Estate, Veera Desai Road, Andheri - West, Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36990MH2017PTC298532

  • Registration Number

    298532

  • Incorporation Date

    11 August 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 6 Months
Company report

Kalayani Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kalayani Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kalayani Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Sangharsh Singh Additional Director 25 Mar 2018 Current
Anuradha Krishna Hedge Director 11 Aug 2017 Current
Udai Bhanu Singh Director 11 Aug 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kalayani Drugs.

Enhance accessibility to Kalayani Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kalayani Drugs revenue growth over time
Kalayani Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kalayani Drugs?

Unlock access to Kalayani Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kalayani Drugs?

Unlock and access historical data on people associated with Kalayani Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kalayani Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalayani Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kalayani Drugs
Recent Activity within the Organization
  • Director Appointment

    Progress on Sangharsh Singh was appointed as a Additional Director was appointed as a Additional Director on 25 Mar 2018 & has been associated with this company since 7 years 11 months . was documented.

  • Director Appointment

    Anuradha Krishna Hedge was appointed as a Director was appointed as a Director on 11 Aug 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.

  • Director Appointment

    Progress on Udai Bhanu Singh was appointed as a Director was appointed as a Director on 11 Aug 2017 & has been associated with this company since 8 years 6 months . was documented.

  • Company Incorporation

    Progress on Kalayani Drugs Private Limited was registered on 11 Aug 2017 with Roc Mumbai & aged 8 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kalayani Drugs Private Limited?

The CIN of Kalayani Drugs Private Limited is U36990MH2017PTC298532.

Where is Kalayani Drugs Private Limited headquartered?

Kalayani Drugs Private Limited is headquartered at 201, Wood Row, Plot -19, Shah Industrial Estate, Veera Desai Road, Andheri - West, Mumbai, Maharashtra, 400053.

When was Kalayani Drugs Private Limited incorporated?

Kalayani Drugs Private Limited was incorporated on 11 August 2017.

Who are the current directors of Kalayani Drugs Private Limited?

The current directors of Kalayani Drugs Private Limited are

What is the primary industry of Kalayani Drugs Private Limited?

The primary industry of Kalayani Drugs Private Limited is Manufacturing.

Is Kalayani Drugs Private Limited a listed company?

Kalayani Drugs Private Limited is unlisted.

What is the capital structure of Kalayani Drugs Private Limited?

The authorized capital of Kalayani Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Kalayani Drugs Private Limited?

The compliance status of Kalayani Drugs Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available